Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02054806 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28) |
| First Submitted : | February 3, 2014 |
| First Submitted that Met QC Criteria : | February 3, 2014 |
| First Posted : | February 4, 2014 (Estimate) |
| Results First Submitted : | April 19, 2022 |
| Results First Submitted that Met QC Criteria : | February 6, 2023 |
| Results First Posted : | October 30, 2023 |
| Last Update Submitted that Met QC Criteria : | February 6, 2023 |
| Last Update Posted : | October 30, 2023 |